MOHAMMAD O BUKHARI
Allopathic & Osteopathic Physicians|Family Medicine ALTOONA, PA NPI 1306334073
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine PA ABBVIE INC. All categories
General Payments — all program years on this page
$816.08
- Category: General Payments
- Program years: PY2020–2022
- Record count: 10
- As of (CMS publication): 2026-01-23
Latest program year (PY2022): $754.53 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2022) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $754.53 | 9 |
By paying entity
Latest program year (PY2022) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $224.88 | 2 |
| Alkermes, Inc. | $105.45 | 1 |
| Novo Nordisk AS | $102.27 | 1 |
| ITI, Inc. | $70.12 | 1 |
| Lilly USA, LLC | $69.53 | 1 |
| Janssen Pharmaceuticals, Inc | $67.55 | 1 |
| GlaxoSmithKline, LLC. | $64.93 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $49.80 | 1 |
By program year
Records — PY2022 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 886824909 | Janssen Pharmaceuticals, Inc | $67.55 | 03/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 890679113 | ABBVIE INC. | $64.80 | 05/12/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 890679115 | ABBVIE INC. | $160.08 | 09/06/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 899279585 | Novo Nordisk Inc | $102.27 | 02/10/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 918208415 | Lilly USA, LLC | $69.53 | 07/21/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 925820449 | Alkermes, Inc. | $105.45 | 10/13/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 945664777 | ITI, Inc. | $70.12 | 06/15/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 949673365 | Boehringer Ingelheim Pharmaceuticals, Inc. | $49.80 | 03/18/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 965476809 | GlaxoSmithKline, LLC. | $64.93 | 11/29/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.